✦ LIBER ✦

Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapy

✍ Scribed by Khaled M. Musallam; Fadi S. Dahdaleh; Ali I. Shamseddine; Ali T. Taher

Book ID: 116913999
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 408 KB
Volume: 123
Category: Article
ISSN: 0049-3848
DOI: 10.1016/j.thromres.2008.09.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PO-02 Incidence of venous thromboembolis

PO-02 Incidence of venous thromboembolism and prophylaxis use in ambulatory cancer patients receiving chemotherapy

✍ E. Panizo; R. Lecumberri; S. Varea; A. García-Mouriz; J.A. Páramo 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Rates of venous thromboembolism in multi

Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta-analysis

✍ M. CARRIER; G. LE GAL; J. TAY; C. WU; A. Y. LEE 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

Incidence and Economic Implications of H

Incidence and Economic Implications of Heparin-Induced Thrombocytopenia in Medical Patients Receiving Prophylaxis for Venous Thromboembolism

✍ Dr. Freddy M. Creekmore; Dr. Gary M. Oderda; Dr. Robert C. Pendleton; Dr. Diana 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Cost and occurrence of thrombocytopenia

Cost and occurrence of thrombocytopenia in patients receiving venous thromboembolism prophylaxis following major orthopaedic surgeries

✍ Laura Elizabeth Happe; Eileen Marie Farrelly; Richard H. Stanford; Matt William 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 275 KB

Prophylactic recombinant erythropoietin

Prophylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxis

✍ Elias J. Anaissie; Elizabeth A. Coleman; Julia A. Goodwin; Robert L. Kennedy; Ki 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 1 views

## Abstract ## BACKGROUND: Venous thromboembolism (VTE) is a significant but poorly understood complication in patients with newly diagnosed multiple myeloma (NDMM). As a result, most patients receive thromboprophylaxis with low molecular weight heparin (LMWH). The purpose of this retrospective st

Characterisation of haematological profi

Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma

✍ Sagar Lonial; Paul G Richardson; Jesús San Miguel; Pieter Sonneveld; Michael W S 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB